Arrowhead Pharmaceuticals, Inc. (ARWR) vs Cytokinetics, Incorporated (CYTK)
A side-by-side comparison of Arrowhead Pharmaceuticals, Inc. and Cytokinetics, Incorporated across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ARWR
Arrowhead Pharmaceuticals, Inc.
$62.76HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
CYTK
Cytokinetics, Incorporated
$62.10HealthcareDelayed quote: Oct 6, 2026, 9:30 AM EDT
Total return — ARWR vs CYTK
growth of $100 · dividends reinvested · last 10yARWR +755.3% (+23.9%/yr)CYTK +570.6% (+21.0%/yr)ARWR compounded faster over this window
ARWR CYTK
ARWR vs CYTK: by the numbers
- •ARWR is the larger company ($8.84B vs $7.73B market cap).
- •Both run net losses; ARWR's is the smaller (-47.79% vs -1259.87% net margin).
- •ARWR grew revenue faster over the past five years (44.14% vs 4.19% CAGR).
Metrics side by side
Valuation
| Metric | ARWR | CYTK |
|---|---|---|
| P/S ratio | 13.20 | 108.90 |
| P/B ratio | 18.99 | N/A |
Profitability
| Metric | ARWR | CYTK |
|---|---|---|
| Gross margin | 100.00% | 84.97% |
| Operating margin | 11.86% | -695.44% |
| Net margin | -47.79% | -1259.87% |
| ROE | -68.73% | N/A |
| ROIC | -12.12% | -39.80% |
Growth (annualized)
| Metric | ARWR | CYTK |
|---|---|---|
| Revenue CAGR (5Y) | 44.14% | 4.19% |
| Total return CAGR (5Y) | 0.75% | 11.24% |
Frequently asked
- Which has grown faster, ARWR or CYTK?
- Over the past five years, ARWR grew revenue faster — ARWR at a 44.14% CAGR versus CYTK at 4.19%.
- How have ARWR and CYTK total returns compared?
- Over the past 10 years, ARWR delivered 23.56% and CYTK delivered 20.95% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Arrowhead Pharmaceuticals ROECytokinetics ROEArrowhead Pharmaceuticals operating marginCytokinetics operating marginArrowhead Pharmaceuticals revenue growthCytokinetics revenue growthArrowhead Pharmaceuticals free cash flowCytokinetics free cash flow
Arrowhead Pharmaceuticals & Cytokinetics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.